Causal relationship between the loss of RUNX3 expression and gastric cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 11955451.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Runx3/Pebp2alphaC null mouse gastric mucosa exhibits hyperplasias due to stimulated proliferation and suppressed apoptosis in epithelial cells, and the cells are resistant to growth-inhibitory and apoptosis-inducing action of TGF-beta, indicating that Runx3 is a major growth regulator of gastric epithelial cells. Between 45% and 60% of human gastric cancer cells do not significantly express RUNX3 due to hemizygous deletion and hypermethylation of the RUNX3 promoter region. Tumorigenicity of human gastric cancer cell lines in nude mice was inversely related to their level of RUNX3 expression, and a mutation (R122C) occurring within the conserved Runt domain abolished the tumor-suppressive effect of RUNX3, suggesting that a lack of RUNX3 function is causally related to the genesis and progression of human gastric cancer.
Medical subject headings
- Cell Division
- Cell Transformation, Neoplastic
- DNA-Binding Proteins
- Epithelium
- Gastric Mucosa
- Stomach Neoplasms
- Transcription Factors
- Tumor Suppressor Proteins